LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Frybourg, Sandrine; Remuzat, Cécile; Kornfeld, Åsa; Toumi, Mondher (2015)
Publisher: Routledge
Journal: Journal of Market Access & Health Policy
Languages: English
Types: Article
Subjects: Research Article, Council of State, HTA, Loi Bertrand, conflict of interest, HAS, Sunshine Act, Debate Pieces
The slow reaction of French authorities to the so-called Mediator® saga in 2009 in France led to investigations that questioned the way conflicts of interest are reported. France implemented the Loi Bertrand (‘Bertrand Law’) in May 2013, known as the ‘French Sunshine Act’, with the aim of specifying the scope of disclosure obligations. This policy research reviewed the Loi Bertrand and reported case law from the French Council of State (COS) related to conflicts of interest in French Health technology assessment (HTA) opinion. The Loi Bertrand requires the publication of most of the agreements concluded between health-care professionals and companies and covers a vast range of health products. Commercial sales agreements of goods and services concluded between manufacturers and health-care professionals are a strong exception to this disclosure obligation. Six cases examined by the COS were analyzed, most of them related to the publication of guidelines or the removal of products from the list of reimbursed drugs and devices. These cases have been reviewed, as well as the impact of the ruling on reimbursement decisions. Four cases led to suspension or invalidation of decisions based on the Haute Autorité de Santé (HAS) recommendations due to conflicts of interest. In the two other cases, the HAS provided post hoc declarations of interest when required by the COS, and the COS considered the conflicts of interest as irrelevant for the decision. It appears that the COS based its decisions on two main criteria: the acknowledgement of negative conflicts of interest (a link with competitors) and the absence of declarations of conflicts of interest, which have to be presented when required by legal authorities irrespective of when they were completed (even posterior to the HAS opinion). However, the number of cases that have been decided against the HAS remains very limited with respect to the volume of assessments performed yearly. The strengthening of the regulation on declarations of interest might lead to more transparency but also to more cases decided by the COS. A new press investigation (in March 2015) related to alleged cases of conflict of interests led policy makers to amend the Bertrand Law in April 2015 and require the disclosure of amounts paid to health-care professionals by the industry.Keywords: conflict of interest; Sunshine Act; Loi Bertrand; HAS; Council of State; HTA(Published: 9 December 2015)Citation: Journal of Market Access & Health Policy 2015, 3: 25682 - http://dx.doi.org/10.3402/jmahp.v3.25682
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Chazan D. France pledges reform after diabetes drug scandal BBC News [Internet]. 2011. Available from: http://www.bbc.co. uk/news/world-europe-12200506 [cited 2014 June 18].
    • 2. Legifrance. [Law no. 2011 2012, related to the reinforcement of the health safety of drugs and health products]. 2011. Available from: http://www.legifrance.gouv.fr/affichTexte.do?cidTexte JORFTEXT000025053440&categorieLien id [cited 2014 June 18].
    • 3. Lo B, Field MJ. Conflict of interest in medical research, education, and practice. Washington, DC: National Academies Press; 2009.
    • 4. Chailland M. [Explanatory dictionary of waters and forests] [Archive], Vol 1, Google books, page 115.
    • 5. Grassley C. Grassley, Kohl say public should know when pharmaceutical makers give money to doctors. 2007. Available from: http://www.grassley.senate.gov/news/news-releases/ grassley-kohl-say-public-should-know-when-pharmaceuticalmakers-give-money [cited 2014 June 18].
    • 6. Federal Register. Medicare, Medicaid, Children's Health Insurance Programs; Transparency reports and reporting of physician ownership or investment interests [updated August 2013]; 2013. Available from: https://www.federalregister.gov/ articles/2013/02/08/2013-02572/medicare-medicaid-childrenshealth-insurance-programs-transparency-reports-and-reportingof [cited 2014 June 18].
    • 7. Mullard A. Mediator scandal rocks French medical community. Lancet. 2011;377:890 2.
    • 8. Le Monde. [Mediator: Two counsellors of Xavier Bertrand in 2006 had acquaintances with Servier]. 2011. Available from: http://www.lemonde.fr/societe/article/2011/01/11/mediator-deuxconseillers-de-xavier-bertrand-en-2006-avaient-des-liens-avecservier_1464316_3224.html [cited 2014 June 18].
    • 9. Haute Autorite´ de Sante´. [Clarification of the Haute Autorite´ de Sante´ on Mediator]. 2010. Available from: http://www.has-sante. fr/portail/jcms/c_1004608/fr/mise-au-point-de-la-haute-autorite-de-sante-sur-mediator [cited 2014 June 18].
    • 10. Legifrance. [Decree no. 2013-414, related to the transparency of benefits granted by enterprises producing or marketing sanitary and cosmetic products intended for human use]. 2013. Available from: http://www.legifrance.gouv.fr/affichTexte. do;jsessionid ?cidTexte JORFTEXT000027434029&date Texte &oldAction rechJO&categorieLien id [cited 2014 June 18].
    • 11. Ministe`re des Affaires sociales et de la Sante´. « Sunshine Act »: [Transparency between health professionals and pharmaceutical industries, and independence of expertise]. 2013. Available from: http://www.social-sante.gouv.fr/actualite-presse,42/communiques, 2322/sunshine-act-transparence-entre,15851.html [cited 2014 June 20].
    • 12. Buthusiem EJ. Here comes le Soleil Franc¸ais: the French Sunshine Act has arrived Corporate compliance insights. 2013. Available from: http://www.corporatecomplianceinsights.com/ here-comes-le-soleil-francais-the-french-sunshine-act-has-arrived/ [cited 2014 June 20].
    • 13. King & Spalding. FDA & Life Sciences Practice Group. French national councils and companies publicly disclose information about interactions with French health care professionals for the first time as required by the French Sunshine Act. Client alert. 2013. Available from: http://www.kslaw.com/imageserver/KSPublic/ library/publication/ca1001b13.pdf [cited 2014 June 20].
    • 14. McDermott Will & Emery. French Sunshine Act finally implemented. 2013. Available from: http://www.mwe.com/FrenchSunshine-Act-Finally-Implemented-05-09-2013/?Publication Types d9093adb-e95d-4f19-819a-f0bb5170ab6d [cited 2014 June 20].
    • 15. Legifrance. [Decree of the 3 December 2013 concerning the operational conditions of the single public website mentioned in Article R. 1453-4 of the Code of Public Health]. 2013. Available from: http://www.legifrance.gouv.fr/affichTexte.do? cidTexte JORFTEXT000028339198&dateTexte &categorie Lien id [cited 2014 June 25].
    • 16. Dhuri S. Comparison of the French Sunshine Act. (Loi Bertrand Law) and the US Sunshine Act. Pharma Marketing and Analytics. 2013. Available from: http://pharmapromotional. wordpress.com/2013/09/30/comparison-of-the-french-sunshineact-loi-bertrand-law-and-the-us-sunshine-act/ [cited 2014 June 20].
    • 17. PotomacRiver Partners. Let the sun shine in France. 2014. Available from: http://potomacriverpartners.com/wp-content/ uploads/2014/05/French-Sunshine-Act-Quickcard_05.06.14.pdf [cited 2014 June 20].
    • 18. Legifrance. [Code of Public Health: Article L5323-4] [updated February 2007]. Available from: http://www.legifrance.gouv.fr/ affichCodeArticle.do?cidTexte LEGITEXT000006072665& idArticle LEGIARTI000006690384&dateTexte 20090331 [cited 2014 June 25].
    • 19. Haute Autorite´ de Sante´. [Committee for ethics and independence of expertise]. 2014 June 17. Available from: http://www. has-sante.fr/portail/jcms/c_1745718/fr/comite-deontologie-etindependance-de-lexpertise [cited 2014 June 25].
    • 20. Haute Autorite´ de Sante´. [Guide for declarations of interest and management of conflicts of interest]. 2013 Jul. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/ guide_dpi.pdf [cited 2014 June 25].
    • 21. Legifrance. [Act n8 93-121 of 27 January 1993 on various social measures]. 1993 Jan. Available from: http://www.legifrance. gouv.fr/affichTexte.do;jsessionid 25C24DFD65DAADAC7896 D7E933081E4B.tpdjo03v_1?cidTexte JORFTEXT00000071 1603&categorieLien id [cited 2014 July 21].
    • 22. La Tribune. [Pharmaceutical firms obliged to declare any ''gift'' to practitioners that costs more than 10 euros]. 2013 May 22. Available from: http://www.latribune.fr/entreprises-finance/indus trie/chimie-pharmacie/20130522trib000765886/les-laboratoiresobliges-de-declarer-tout-cadeau-aux-medecins-de-plus-de-10- euros.html [cited 2014 July 21].
    • 23. Council of State [Internet]. Available from: http://www.conseiletat.fr/en [cited 2014 June 18].
    • 24. Legifrance. [Council of State N8 334396]. 2011 Apr 27. Avalaible from: http://www.legifrance.gouv.fr/affichJuriAdmin. do?idTexte CETATEXT000023946448 [cited 2014 June 18].
    • 25. Haute Autorite´ de Sante´. [Decision N82011.05.064/MJ]. 2011 May 18. Available from: http://www.has-sante.fr/portail/up load/docs/application/pdf/2011-05/2011_05_064_abrogation_ reco_alzheimer.pdf [cited 2014 June 20].
    • 26. Haute Autorite´ de Sante´. [Independence of expertise: the Haute Autorite´ de Sante´ keeps its commitments]. 2011 Sept 19. Available from: http://www.has-sante.fr/portail/jcms/c_109 7497/fr/independance-de-lexpertise-la-haute-autorite-de-santetient-ses-engagements?xtmc &xtcr 317 [cited 2014 June 25].
    • 27. Pesty F. [Conflicts of interest: the dirty laundry of the HAS]. 2010 Sep 4. Available from: http://www.formindep.org/Conflitsd-interets-La-mauvaise.html [cited 2014 July 15].
    • 28. Legifrance. [Council of State N8290164]. 2007 Feb 12. Available from: http://www.legifrance.gouv.fr/affichJuriAdmin.do? oldAction rechExpJuriAdmin&idTexte CETATEXT00001800 5511 [cited 2014 June 20].
    • 29. Legifrance. [Council of State N8353992]. 2011 Dec 1. Available from: http://www.legifrance.gouv.fr/affichJuriAdmin.do;jsessio nid 726274939A77E4318762ED753F14A176.tpdjo17v_2?old Action rechExpJuriAdmin&idTexte CETATEXT00002494 2978&fastReqId 298834279&fastPos 2 [cited 2014 June 20].
    • 30. Legifrance. [Council of State N8 361965]. 2012 Sep 5. Available from: http://www.legifrance.gouv.fr/affichJuriAdmin.do?old Action rechJuriAdmin&idTexte CETATEXT000026355168& fastReqId 655378635&fastPos 4 [cited 2014 June 20].
    • 31. Legifrance. [Council of State N8 349431, 349432, 349433, 349434, 350058, 350067, 350083 et 350125]. 2012 Feb 17. Available from: http://www.legifrance.gouv.fr/affichTexte.do?cidTexte JORF TEXT000025391809 [cited 2014 June 25].
    • 32. Legifrance. [Council of State N8 344490]. 2013 Nov 13. Available from: http://www.legifrance.gouv.fr/affichJuriAdmin.do?old Action rechJuriAdmin&idTexte CETATEXT000028195232& fastReqId 1465927594&fastPos 1 [cited 2014 June 25].
    • 33. Haute Autorite´ de Sante´. [The Transparency Committee]. 2014 March. Available from: http://www.has-sante.fr/portail/upload/ docs/application/pdf/2014-03/commission_transparence_2014_ v4.pdf [cited 2014 July 15].
    • 34. Mascret C. [Analysis of the jurisprudence relating to the links of interest on the reimbursement of medicines]. [Small posters]. 2014 Jan 29: N821.
    • 35. Formindep. [Appeal of Formindep to the Council of State] N81265508245273413. 2013 Jul 22. Available from: http://www. formindep.org/IMG/pdf/recours_contre_decret2013-414.pdf [cited 2014 July 15].
    • 36. Formindep. [Appeal of Formindep to the Council of State] N81265508245363041. 2013 July 22. Available from: http://www. formindep.org/IMG/pdf/recours_contre_decret2013-413.pdf [cited 2014 July 15].
    • 37. Benkimoun P. French ''sunshine act'' sheds little light on drug industry's payments to doctors, say critics. BMJ. 2013; 346:f3762.
    • 38. Masquellier P. [Formindep raises the matter to the Council of State once again]. 2013 Aug 21. Available from: http://www. formindep.org/Le-Formindep-saisit-a-nouveau-le,580.html [cited 2014 July 15].
    • 39. Reaction of the CNOM to the decree: an appeal to the Council of State is considered. Bertrand Law - Health Transparency [Blog]. 2013 May 23. Available from: http://market-it.fr/loiber trand/1397/loi-bertrand/reaction-du-cnom-au-decret-un-recoursau-conseil-detat-est-envisage/ [cited 2014 July 15].
    • 40. Legifrance. [Council of State N8 369074]. 2015 Feb 24. Available from: http://www.legifrance.gouv.fr/affichJuriAdmin.do?old Action rechJuriAdmin&idTexte CETATEXT000030283091& fastReqId 535128492&fastPos 1 [cited 2015 April 17].
    • 41. Le Monde. [Medicines: investigation on potential conflicts of interest between pharmaceutical firms and authorities]. 2015 April 09. Available from: http://www.latribune.fr/entreprisesfinance/industrie/chimie-pharmacie /medicaments -enquetesur-d-eventuels-conflits-d-interets-entre-laboratoires-et-autorites467575.html [cited 2015 April 20].
    • 42. Haute Autorite´ de Sante´. [Drugs assessment: the HAS reacts to information in the press]. 2014 March 26. Available from: http://www.has-sante.fr/portail/jcms/c_2023653/fr/evaluation-desmedicaments-la-has-reagit-aux-informations-relatees-par-lapresse?cid fc_1249740 [cited 2015 April 20].
    • 43. ANSM. [The ANSM initiates an internal administrative inquiry following the information reported by the press] [Press Release. 2014 March 26. Available from: http://ansm.sante.fr/Sinformer/Presse-Communiques-Points-presse/L-ANSM-engageune-enquete-administrative-interne-sur-les-faits-rapportes-parla-presse-Communique [cited 2015 April 20].
    • 44. Le Monde. [Clean hands operation in Health]. 2015 Apr 09. Available from: http://www.lemonde.fr/economie/article/2015/ 04/09/operation-mains-propres-dans-la-sante_4612785_3234. html#DcG3VVkpplctHLYO.99 [cited 2015 April 20].
    • 45. Assemble´e Nationale. [Amendment N82505]. 2015 April 9. Available from: http://www.assemblee-nationale.fr/14/amendements/ 2673/AN/2505.asp [cited 2015 April 20].
    • 46. Haute Autorite´ de Sante´. [2013 annual activity report]. 2014 July 1. Available from: http://www.has-sante.fr/portail/upload/ docs/application/pdf/2014-06/rapport_acitivite_has_2013.pdf [cited 2015 April 17].
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article